Changeflow GovPing Pharma & Drug Safety Patent for Retinyl Ester Production
Routine Notice Added Final

Patent for Retinyl Ester Production

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Biotech (C12N)
Published March 25th, 2026
Detected April 1st, 2026
Email

Summary

The European Patent Office published patent application EP3687487A1 for DSM IP Assets B.V., covering methods for producing retinyl esters. The patent describes enzyme-based production processes classified under IPC A61K 8/67 and C12N 9/10, with designated states covering the EU and broader European region. This patent has applications in pharmaceutical and cosmetic formulations.

What changed

EPO published patent EP3687487A1 for DSM IP Assets B.V. covering production methods for retinyl esters. The patent includes nine named inventors and covers compositions and methods under IPC classifications A61K 8/67 (cosmetic preparations with vitamins), A61K 31/07 (retinoid preparations), and C12N 9/10 (transferase enzymes). The designation covers all EU member states plus associated European countries.

Companies developing products involving retinyl esters or related enzymatic processes should review the patent claims to assess potential infringement risks. Parties seeking to use the patented production methods may need to pursue licensing arrangements with DSM IP Assets B.V. The patent publication is informational and does not impose compliance obligations on third parties.

Source document (simplified)

← EPO Patent Bulletin

PRODUCTION OF RETINYL ESTERS

Publication EP3687487A1 Kind: A1 Mar 25, 2026

Applicants

DSM IP Assets B.V.

Inventors

BALCH, Nathalie, BLOMQUIST, Paul, DOTEN, Reed, HOUSTON, Peter, LAM, Ethan, MCMAHON, Jenna, TRUEHEART, Joshua, VIAROUGE, Celine, DE JONG, René, Marcel

IPC Classifications

A61K 8/67 20060101AFI20190329BHEP A61K 31/07 20060101ALI20190329BHEP C12N 9/10 20060101ALI20190329BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

Production of Retinyl Esters

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 25th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP3687487A1

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers Consumers
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Patent Issuance
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Intellectual Property Consumer Protection

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.